Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Cheng

Showing results (711-720 of 768) with videos related to

Pageof 77
Sort By:
Cell Transplantation|September 9, 2014
Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic MicePei-Jiun Tsai, Hwai-Shi Wang, Gu-Jiun Lin, et al.
Gigascience|April 4, 2017
Updated foxtail millet genome assembly and gene mapping of nine key agronomic traits by resequencing a RIL populationXuemei Ni, Qiuju Xia, Houbao Zhang, et al.
Journal of the Chinese Medical Association : JCMA|January 22, 2025
Insufficient pretransplant induction therapy is associated with diffuse intrahepatic cholangiopathy in ABO-incompatible living donor liver transplantation for acute liver failureChih-Yao Hu, Cheng-Yen Chen, Hsin-Lin Tsai, et al.
Nature Biomedical Engineering|October 21, 2024
Downregulating human leucocyte antigens on mesenchymal stromal cells by epigenetically repressing a β<sub>2</sub>-microglobulin super-enhancerFei Wang, Ran Li, Jing Yi Xu, et al.
Signal Transduction and Targeted Therapy|March 6, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphomaJie Xiong, Shu Cheng, Xiao Gao, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2Stephanie Brumfield, Julius J Matasi, Deen Tulshian, et al.
The Journal of Biological Chemistry|June 7, 2006
Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336Waldemar Gonsiorek, David Hesk, Shu-Cheng Chen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 11, 2008
CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004Peter A McCullough, Suying Li, Claudine T Jurkovitz, et al.
International Journal of Nursing Studies|May 24, 2025
Acupuncture for women undergoing in vitro fertilization: An updated systematic review and meta-analysis with trial sequential analysisQin-Wei Fu, Shao-Mi Zhu, Ji Chen, et al.
Genome Medicine|May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.
Pageof 77

Showing results (711-720 of 768) with videos related to

Sort By:
Pageof 77
Cell Transplantation|September 9, 2014
Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic MicePei-Jiun Tsai, Hwai-Shi Wang, Gu-Jiun Lin, et al.
Gigascience|April 4, 2017
Updated foxtail millet genome assembly and gene mapping of nine key agronomic traits by resequencing a RIL populationXuemei Ni, Qiuju Xia, Houbao Zhang, et al.
Journal of the Chinese Medical Association : JCMA|January 22, 2025
Insufficient pretransplant induction therapy is associated with diffuse intrahepatic cholangiopathy in ABO-incompatible living donor liver transplantation for acute liver failureChih-Yao Hu, Cheng-Yen Chen, Hsin-Lin Tsai, et al.
Nature Biomedical Engineering|October 21, 2024
Downregulating human leucocyte antigens on mesenchymal stromal cells by epigenetically repressing a β<sub>2</sub>-microglobulin super-enhancerFei Wang, Ran Li, Jing Yi Xu, et al.
Signal Transduction and Targeted Therapy|March 6, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphomaJie Xiong, Shu Cheng, Xiao Gao, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2Stephanie Brumfield, Julius J Matasi, Deen Tulshian, et al.
The Journal of Biological Chemistry|June 7, 2006
Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336Waldemar Gonsiorek, David Hesk, Shu-Cheng Chen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 11, 2008
CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004Peter A McCullough, Suying Li, Claudine T Jurkovitz, et al.
International Journal of Nursing Studies|May 24, 2025
Acupuncture for women undergoing in vitro fertilization: An updated systematic review and meta-analysis with trial sequential analysisQin-Wei Fu, Shao-Mi Zhu, Ji Chen, et al.
Genome Medicine|May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.
Pageof 77